BX Swiss TOP 30 CHF

BX Swiss TOP 30 CHF handeln
1.436,98 PKT +8,05 PKT +0,56 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

WKN SL0CLV

ISIN DE000SL0CLV3


Analysen zu BX Swiss TOP 30 CHF-Werten

Datum Rating Analyst
16.01.15 Novartis Neutral Goldman Sachs Group Inc.
16.01.15 Swiss Re Neutral Goldman Sachs Group Inc.
16.01.15 UBS buy Goldman Sachs Group Inc.
16.01.15 Nestlé Sell Goldman Sachs Group Inc.
16.01.15 ABB (Asea Brown Boveri) Sell Deutsche Bank AG
16.01.15 Zurich Insurance buy Goldman Sachs Group Inc.
16.01.15 UBS buy Goldman Sachs Group Inc.
15.01.15 UBS Market Perform Cowen and Company, LLC
15.01.15 UBS overweight JP Morgan Chase & Co.
15.01.15 Novartis Hold Deutsche Bank AG
15.01.15 Roche buy Deutsche Bank AG
15.01.15 UBS Outperform FBR Capital
15.01.15 Zurich Insurance Neutral HSBC
15.01.15 Swiss Re Neutral HSBC
14.01.15 UBS Neutral UBS AG
14.01.15 UBS Conviction Buy List Goldman Sachs Group Inc.
14.01.15 Swiss Re Neutral Citigroup Corp.
14.01.15 Zurich Insurance Neutral Citigroup Corp.
14.01.15 Nestlé Reduce Nomura
14.01.15 Zurich Insurance Neutral JP Morgan Chase & Co.
14.01.15 Roche overweight JP Morgan Chase & Co.
13.01.15 UBS buy Deutsche Bank AG
13.01.15 UBS buy Deutsche Bank AG
14.01.15 ABB (Asea Brown Boveri) Neutral JP Morgan Chase & Co.
13.01.15 UBS overweight Morgan Stanley
14.01.15 UBS Equal-Weight Morgan Stanley
13.01.15 ABB (Asea Brown Boveri) Neutral Merrill Lynch & Co., Inc.
12.01.15 UBS buy Société Générale Group S.A. (SG)
12.01.15 Nestlé Neutral BNP PARIBAS
12.01.15 Swiss Re Underweight JP Morgan Chase & Co.
12.01.15 Zurich Insurance Neutral JP Morgan Chase & Co.
12.01.15 Givaudan Neutral Citigroup Corp.
09.01.15 Swiss Re neutral Bernstein Research
09.01.15 Roche Neutral UBS AG
09.01.15 Zurich Insurance Sell Société Générale Group S.A. (SG)
09.01.15 Givaudan buy Deutsche Bank AG
08.01.15 Givaudan overweight JP Morgan Chase & Co.
08.01.15 Nestlé overweight JP Morgan Chase & Co.
08.01.15 UBS Neutral Merrill Lynch & Co., Inc.
08.01.15 UBS Underperform Merrill Lynch & Co., Inc.